Table 2 Intraoperative recipient, donor-graft, and early postoperative parameters in the non-infected and infected groups
Group | non-Infection | Infection | p |
|---|---|---|---|
n | 539 | 57 | Â |
Intraoperative recipient parameters | |||
Surgical duration (min) | 500 (450– 565) | 515 (453–590) | 0.364 |
Post-reperfusion syndrome | 119 (22.1%) | 19 (33.3%) | 0.055 |
Mean vital sign values | |||
 MBP (mmHg) | 74 (68–80) | 75 (70–79) | 0.826 |
 HR (beats·min-1) | 90 (80–100) | 93 (79–103) | 0.363 |
 CVP (mmHg) | 9 (7–11) | 10 (7–13) | 0.146 |
Mean lactate (mmol·L-1) | 3.7 (2.9–5.0) | 3.6 (2.7–5.1) | 0.493 |
Blood product transfusion (unit) | |||
 Packed red blood cells | 8 (4–13) | 10 (5–21) | 0.005 |
 Fresh frozen plasma | 7 (4–11) | 8 (5–12) | 0.102 |
 Single donor platelet | 1 (0–2) | 1 (0–2) | 0.208 |
Hourly fluid infusion (mL·kg-1·h-1) | 9.6 (6.7–13.1) | 10.5 (8.0–16.8) | 0.012 |
Hourly urine output (mL·kg-1·h-1) | 1.2 (0.6–2.0) | 1.0 (0.2–1.7) | 0.021 |
Donor-graft parameters | |||
Age (years) | 35 (26–41) | 35 (29–40) | 0.346 |
Sex (male) | 175 (32.5%) | 19 (33.3%) | 0.894 |
Body mass index (kg·m-2) | 23.8 (21.9–25.3) | 23.8 (22.1–25.1) | 0.993 |
GRWR (%) | 1.2 (1.0–1.5) | 1.2 (1.0–1.6) | 0.68 |
ABO-incompatible graft (%) | 48 (8.9%) | 7 (12.3%) | 0.402 |
Graft ischemic time (min) | 95 (70–128) | 95 (67–137) | 0.852 |
Graft fatty change (%) | 4.7 (1.0–5.0) | 4.7 (1.5–5.0) | 0.138 |
Early postoperative parameters | |||
Early allograft dysfunction | 64 (11.9%) | 20 (35.1%) | <0.001 |
Acute kidney injury | 157 (29.1%) | 22 (38.6%) | 0.142 |
Biliary stricture or leakage | 81 (15.0%) | 12 (21.1%) | 0.233 |
Mechanical ventilation duration (min) | 25 (0 – 765) | 70 (0 – 711) | 0.692 |
Acute graft rejection | 109 (20.2%) | 7 (12.3%) | 0.15 |
 Rejection activity index (score)a | 4 (2 – 6) | 3 (2 – 4) | 0.071 |
  Mild rejection (0 – 3 score) | 50 (45.9%) | 4 (57.1%) | 0.843 |
  Moderate rejection (4 – 6 score) | 38 (34.9%) | 2 (28.6%) |  |
  Severe rejection (7 – 9 score) | 21 (19.3%) | 1 (14.3%) |  |